Humira 40 mg (Adalimumab) Injection – 2 Pack

Humira 40 mg is a prescription-only biologic medication containing the active ingredient Adalimumab. It is a self-injectable therapy used to treat a wide range of chronic inflammatory and autoimmune conditions, including rheumatoid arthritis (RA), psoriatic arthritis, and Crohn’s disease. This package contains 2 pre-filled pens (or syringes) (40 mg/0.4 ml each), manufactured by AbbVie.

Product Overview: Humira 40 mg (Adalimumab)

Humira (Adalimumab) is a highly specialized medication known as a tumor necrosis factor (TNF) blocker. It is a biologic, meaning it is derived from living organisms. Humira is not a simple chemical pill; it is a complex antibody designed to target a specific source of inflammation in the body.

This therapy is prescribed for adults (and sometimes children, depending on the condition) to reduce the signs and symptoms of several chronic autoimmune diseases, including:

• Rheumatoid Arthritis (RA)
• Psoriatic Arthritis
• Ankylosing Spondylitis (AS)
• Crohn’s Disease
• Ulcerative Colitis (UC)
• Plaque Psoriasis

Humira works by modifying the body’s own immune system to reduce inflammation, which in turn helps to relieve pain, stiffness, and joint damage.

How Does Humira 40 mg (Adalimumab) Work?

The active ingredient, Adalimumab, is a monoclonal antibody. In many autoimmune diseases, the body’s immune system mistakenly attacks its own healthy tissues. It does this, in part, by overproducing a protein called Tumor Necrosis Factor-alpha (TNF-alpha).

TNF-alpha is a key driver of systemic inflammation. Humira works by finding, binding to, and blocking the action of TNF-alpha. By neutralizing this specific protein, Humira helps to “calm” the overactive immune response, thereby reducing inflammation and its damaging effects on the body.

Key Product Details

Dosage and Administration

Humira is administered as a subcutaneous injection (an injection under the skin). The dosage and frequency are determined entirely by your doctor based on your specific condition, weight, and response to treatment.

• For many conditions, such as rheumatoid arthritis, the typical adult dose is one 40 mg injection every other week.
• Your healthcare provider will provide full training on how to properly store and self-administer the injection.

Important: This is a prescription-only medication. You must follow the exact dosage and administration schedule prescribed by your specialist (e.g., a rheumatologist or gastroenterologist). Do not attempt to inject Humira without proper medical training.

Frequently Asked Questions (FAQ) about Humira 40 mg

How long does it take for Humira to work?

Response times vary. Some patients may notice an improvement in their symptoms within 2 to 4 weeks. For others, it may take up to 12 weeks (or longer) to experience the full benefits of the medication.

How is Humira stored?

Humira must be stored in a refrigerator (between 2°C and 8°C or 36°F and 46°F). Do not freeze it. It must be protected from light. If traveling, it can be stored at room temperature (up to 25°C or 77°F) for a limited period (typically up to 14 days), but it must be discarded if not used within that time.

What is a “biologic” medication?

A biologic is a sophisticated drug derived from living sources (like cells or proteins). Unlike traditional chemical drugs, biologics target very specific parts of the immune system. Humira is a biologic that specifically targets TNF-alpha.

What are the most important side effects of Humira?

The most common side effect is an injection site reaction (redness, itching, pain, or swelling). Because Humira affects the immune system, the most serious side effects are an increased risk of serious infections (like tuberculosis (TB), fungal infections, and bacterial infections) and a potential, though rare, increased risk of certain types of cancers (like lymphoma). Your doctor will screen you for TB before you start treatment.

Important Safety Information

Humira (Adalimumab) is an immunosuppressant and carries significant risks.

WARNING: SERIOUS INFECTIONS AND MALIGNANCY

• Serious Infections: Patients treated with Humira are at an increased risk for developing serious infections that may lead to hospitalization or death. These infections include tuberculosis (TB), bacterial sepsis, and invasive fungal infections. Your doctor must test you for TB before starting Humira and monitor you for signs of infection during treatment.
• Malignancy: Lymphoma and other malignancies, some fatal, have been reported in children and adults treated with TNF blockers like Humira.

Before taking Humira 40 mg, you must inform your doctor of your complete medical history, including:

• If you have any type of infection or have infections that keep coming back.
• If you have or have had tuberculosis (TB) or have been in close contact with someone with TB.
• If you have or have had cancer.
• If you have symptoms of heart failure.
• If you have a nervous system disorder like multiple sclerosis (MS).
• If you are scheduled to receive any vaccines.

Disclaimer: This content is for informational purposes only. Humira (Adalimumab) is a potent prescription biologic medication with serious risks. It is not a substitute for professional medical advice from a qualified healthcare provider.